Biocryst Pharmaceuticals (BCRX) Assets: 2010-2014
Historic Assets for Biocryst Pharmaceuticals (BCRX) over the last 5 years, with Dec 2014 value amounting to $136.9 million.
- Biocryst Pharmaceuticals' Assets rose 1.34% to $139.0 million in Q3 2015 from the same period last year, while for Sep 2015 it was $139.0 million, marking a year-over-year increase of 1.34%. This contributed to the annual value of $136.9 million for FY2014, which is 180.10% up from last year.
- According to the latest figures from FY2014, Biocryst Pharmaceuticals' Assets is $136.9 million, which was up 180.10% from $48.9 million recorded in FY2013.
- In the past 5 years, Biocryst Pharmaceuticals' Assets ranged from a high of $136.9 million in FY2014 and a low of $48.9 million during FY2013.
- Its 3-year average for Assets is $81.1 million, with a median of $57.4 million in 2012.
- As far as peak fluctuations go, Biocryst Pharmaceuticals' Assets crashed by 30.13% in 2012, and later surged by 180.10% in 2014.
- Over the past 5 years, Biocryst Pharmaceuticals' Assets (Yearly) stood at $109.4 million in 2010, then decreased by 24.89% to $82.2 million in 2011, then slumped by 30.13% to $57.4 million in 2012, then decreased by 14.93% to $48.9 million in 2013, then spiked by 180.10% to $136.9 million in 2014.